NancyLeeMDFASTRO

Physician

Overview of Dr. Lee

Dr. Nancy Lee is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Rutgers New Jersey Medical School and has been in practice 29 years. Dr. Lee accepts several types of health insurance, listed below. She is one of 106 doctors at Memorial Sloan Kettering Cancer Center and one of 26 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Radiation Oncology. She has more than 100 publications and over 500 citings.

Office
530 East 74th Street
New York, NY 10021
Book by Phone+1(262) 732-5451

Education & Training

New York Presbyterian Hospital (Columbia Campus)Residency, Radiation Oncology, 1996 - 2000
Jersey Shore University Medical CenterInternship, Transitional Year, 1995 - 1996
Rutgers New Jersey Medical SchoolClass of 1995

Certifications & Licensure

CA State Medical License 2000 - Present
FL State Medical License 2023 - Present
NY State Medical License 2002 - 2026
NJ State Medical License 1996 - 2025
PA State Medical License 2020 - 2020
American Board of Radiology Radiation Oncology

Clinical Trials

Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer Start of enrollment: 2003 Feb 01
Completed
Phase 2
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer Start of enrollment: 2006 Dec 13
Completed
Phase 2
Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients Start of enrollment: 2004 Jun 01
Completed
Not Applicable
Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma Start of enrollment: 2005 Mar 01
Completed
A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3D-CRT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer Start of enrollment: 2006 Dec 01
Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer Start of enrollment: 2013 Jun 13
Completed
Phase 2
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer Start of enrollment: 2017 Apr 25
Completed
Phase 1
Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma Start of enrollment: 2017 Oct 16
Active, not recruiting
Phase 2
Proton Re-Irradiation for Recurrent Head and Neck Cancer Start of enrollment: 2017 Jul 10
Active, not recruiting
Phase 2
Roles: Principal Investigator, Contact
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC) Start of enrollment: 2022 Mar 24
Recruiting
Phase 2
Roles: Contact
Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer Start of enrollment: 2013 Aug 26
Active, not recruiting
Phase 2, Phase 3
Roles: Principal Investigator, Contact
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer Start of enrollment: 2022 Aug 04
Recruiting
Phase 2
Roles: Principal Investigator, Contact
A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC) Start of enrollment: 2023 Mar 31
Recruiting
Roles: Principal Investigator, Contact
A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer Start of enrollment: 2022 Sep 30
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

925 citations
Chromosomal instability drives metastasis through a cytosolic DNA response.
Samuel F. Bakhoum, Bryan Ngo, Ashley M. Laughney, Julie Ann Cavallo, Charles J. Murphy
Nature. 2018-01-17
99 citations
International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma.
Anne W.M. Lee, Wai Tong Ng, Jianji Pan, Chi-Leung Chiang, Sharon Shuxian Poh
International Journal of Radiation Oncology, Biology, Physics. 2019-11-01
10 citations
Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase ...
Eric J Sherman, Jonathan Harris, Keith C Bible, Ping Xia, Ronald A Ghossein
The Lancet. Oncology. 2023-02-01

Journal Articles

Long‐Term Quality of Life in Older Patients with HPV‐Related Oropharyngeal Cancer
Han Xiao, Nancy Y Lee, Head & Neck
Comparing Intensity-Modulated Proton Therapy with Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey from Clinical Trial Concept to Activation
Steven J Frank, G Brandon Gunn, Adam S Garden, Katherine Hutcheson, Paul M Busse, Merrill S Kies, Nancy Y Lee, Alexander Lin, Erich M Sturgis, C David Fuller, J Jack L..., ScienceDirect
International Guideline for the Delineation of the Clinical Target Volumes (CTV) for Nasopharyngeal Carcinoma
William M. Mendenhall, Qunyh-Thu Le, Nancy Y. Lee, Radiotherapy & Oncology

Other

Treatment of early (stage I and II) head and neck cancer: The oral cavity
Lee NY, Gross ND, Okuno S, Rao SS
http://www.uptodate.com/contents/treatment-of-early-stage-i-and-ii-head-and-neck-cancer-the-oral-cav
UpToDate, Wolters Kluwer Health - 2012-11-27
Treatment of locoregionally advanced (stage III and IV) head and neck cancer: The oral cavity
Lee NY, Gross ND, Okuno S, Rao SS
http://www.uptodate.com/contents/treatment-of-locoregionally-advanced-stage-iii-and-iv-head-and-neck
UpToDate, Wolters Kluwer Health - 2012-11-06

Press Mentions

Proton Therapy Reirradiation in Recurrent Head and Neck Squamous Cell CarcinomaFebruary 9th, 2023
Expert Highlights Avelumab Trial and Future of Immunotherapy in Head and Neck CancerAugust 8th, 2017
A Case for Radiation Enhancement in Head and Neck CancerMarch 12th, 2024
Join now to see all

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Texas BlueChoice
CIGNA HMO
CIGNA Open Access
CIGNA PPO
GHI PPO
Great West PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment